Muhammad Aron Pase, “Tirzepatide: Dual GIP/GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity”, InaJEMD, vol. 1, no. 2, pp. 96–110, Dec. 2024, doi: 10.66266/inajemd.v1i2.23.